2,678
Views
14
CrossRef citations to date
0
Altmetric
Review

Using PAMPs and DAMPs as adjuvants in cancer vaccines

, , , , ORCID Icon, , , , , & ORCID Icon show all
Pages 5546-5557 | Received 01 Apr 2021, Accepted 31 Jul 2021, Published online: 14 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sunil S. Badve & Yesim Gökmen-Polar. (2023) Targeting the Tumor-Tumor Microenvironment Crosstalk. Expert Opinion on Therapeutic Targets 27:6, pages 447-457.
Read now

Articles from other publishers (13)

Caroline Leal Rodrigues Soares, Polrat Wilairatana, Larissa Rodrigues Silva, Polyanna Silva Moreira, Nayana Maria Medeiros Vilar Barbosa, Pablo Rayff da Silva, Henrique Douglas Melo Coutinho, Irwin Rose Alencar de Menezes & Cícero Francisco Bezerra Felipe. (2023) Biochemical aspects of the inflammatory process: A narrative review. Biomedicine & Pharmacotherapy 168, pages 115764.
Crossref
Dun Niu, Yaran Wu & Jiqin Lian. (2023) Circular RNA vaccine in disease prevention and treatment. Signal Transduction and Targeted Therapy 8:1.
Crossref
Danyang ZhaoRongli Yang, Sibo LiuDong GeXiaolei Su. (2023) Study on the Characteristics of Early Cytokine Storm Response to Cardiac Surgery. Journal of Interferon & Cytokine Research 43:8, pages 351-358.
Crossref
Xinyu Wang, Qian-Nan Jia, Mengyin Wu, Mingjuan Liu & Jun Li. (2023) A Bibliometric Analysis of Melanoma Treated with Vaccinations Research from 2013 to 2023: A Comprehensive Review of the Literature. Vaccines 11:6, pages 1113.
Crossref
Xiaohui Liu, Ning Jiang & Wenxia Zhou. (2023) Various Energetic Metabolism of Microglia in Response to Different Stimulations. Molecules 28:11, pages 4501.
Crossref
Qi Sun, Zhenzhen Yang & Xianrong Qi. (2023) Design and Application of Hybrid Polymer-Protein Systems in Cancer Therapy. Polymers 15:9, pages 2219.
Crossref
David W. Greening, Rong Xu, Anukreity Ale, Christoph E. Hagemeyer & Weisan Chen. (2023) Extracellular vesicles as next generation immunotherapeutics. Seminars in Cancer Biology 90, pages 73-100.
Crossref
Assia Angelova, Kristina Pierrard, Claudia N. Detje, Estelle Santiago, Annabel Grewenig, Jürg P. F. Nüesch, Ulrich Kalinke, Guy Ungerechts, Jean Rommelaere & Laurent Daeffler. (2023) Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells. Pathogens 12:4, pages 607.
Crossref
Maria Leśniak, Justyna Lipniarska, Patrycja Majka, Weronika Kopyt, Monika Lejman & Joanna Zawitkowska. (2023) The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Vaccines 11:2, pages 277.
Crossref
Viktoria Plackoska, Dania Shaban & Anastasia Nijnik. (2022) Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression. Frontiers in Immunology 13.
Crossref
Zheng Gong, Ming Chen, Jie Miao, Chao-Jie Han, Qiao Zhong, Fang-Yuan Gong & Xiao-Ming Gao. (2022) Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma. Journal of Immunology Research 2022, pages 1-10.
Crossref
Ziyin Huang, Cassandra E. Callmann, Shuya Wang, Matthew K. Vasher, Michael Evangelopoulos, Sarah Hurst Petrosko & Chad A. Mirkin. (2022) Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy. ACS Central Science 8:6, pages 692-704.
Crossref
Geoffrey Dusheiko. (2021) Hepatitis B prevalence in pregnant women in China: Progress and realities. The Lancet Regional Health - Western Pacific 16, pages 100289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.